Results 171 to 180 of about 13,218 (206)

Process for the preparation of darunavir and darunavir intermediates

2011
MIZHIRITSKII MICHAEL, MAROM EHUD
openaire   +4 more sources

HIV-1 resistance rarely observed in subjects using darunavir once-daily regimens across clinical studies

HIV Clinical Trials, 2017
Erkki Lathouwers, Eric Y. Wong, Sareh Seyedkazemi   +2 more
exaly  

POLYMORPHS OF DARUNAVIR

2011
PARTHASARADHI REDDY BANDI, RATHNAKAR REDDY KURA, MURALIDHARA REDDY DASARI, RAJI REDDY RAPOLU, SUBASH CHANDER REDDY KESIREDDY, VAMSI KRISHAN BANDI   +5 more
openaire   +4 more sources

Issues Related to Patent Protecton of Darunavir and its Analogs

Pharmaceutical Chemistry Journal, 2016
Alexander A Korlyukov, N L Shimanovskii, K Yu Suponitskii   +2 more
exaly  

Darunavir

2013
openaire   +1 more source

Darunavir/Ritonavir Pharmacokinetics Following Coadministration With Clarithromycin in Healthy Volunteers

Journal of Clinical Pharmacology, 2008
Tony Vangeneugden, Martine de Pauw, Richard M W Hoetelmans   +2 more
exaly  

CRYSTALLINE DARUNAVIR

2013
VELLANKI SIVA RAMA PRASAD, SAHU ARABINDA, PHADHURI NAVEEN KUMAR, KILARU RAVINDRABABU   +3 more
openaire   +2 more sources

Simultaneous Pharmacogenetics-Based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV-Infected Patients

Clinical Pharmacokinetics, 2013
George Xinarianos, Marta Valle, Sudeep P Pushpakom   +2 more
exaly  

Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy†,‡,§

HIV Medicine, 2012
Philippe Flandre, Lise Cuzin, J L Meynard   +2 more
exaly  

Cobicistat/darunavir

Reactions Weekly, 2019
openaire   +2 more sources